English

TETRAGENEX PHARMACEUTICALS, INC.

EDGAR

Quarterly report (10-Q) · filed 2010-11-19

19 filing records in this dataset, filed from 2007-03-30 to 2010-11-19. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

0 USD

2010-03-31 · USD

Exact inputs and evidence

Revenue: 0 USD Source

Operating cash flow

65.6 thousand USD

2010-03-31 · USD

Exact inputs and evidence

Operating Cash Flow: 65576 USD Source

Free cash flow

65.6 thousand USD

2010-03-31 · USD

Exact inputs and evidence

Operating Cash Flow: 65576 USD Source
Capital Expenditure: 0 USD Source

Cash and cash equivalents: 116 thousand USD 2010-09-30 Source
Exact value

115708 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Net income

1.18 million USD

2009-10-01 – 2010-09-30

Exact inputs and evidence

Net income: 34285 USD · 2009-01-01 – 2009-12-31 Source
Net income: -1895672 USD · 2009-01-01 – 2009-09-30 Source
Net income: -235306 USD · 2010-01-01 – 2010-03-31 Source
Net income: -238772 USD · 2010-04-01 – 2010-06-30 Source
Net income: -271839 USD · 2010-07-01 – 2010-09-30 Source

Operating cash flow

-50.4 thousand USD

2009-10-01 – 2010-09-30

Exact inputs and evidence

Operating cash flow: -375384 USD · 2009-01-01 – 2009-12-31 Source
Operating cash flow: -340881 USD · 2009-01-01 – 2009-09-30 Source
Operating cash flow: 65576 USD · 2010-01-01 – 2010-03-31 Source
Operating cash flow: 45751 USD · 2010-01-01 – 2010-06-30 Source
Operating cash flow: 65576 USD · 2010-01-01 – 2010-03-31 Source
Operating cash flow: -15930 USD · 2010-01-01 – 2010-09-30 Source
Operating cash flow: 45751 USD · 2010-01-01 – 2010-06-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2010-11-19.

Financial data available through: 2009-12-31.

Coverage by financial measure

Revenue: 5 of 11 periods available· newest 2009-12-31
operating income: No compatible figures in this window
Net income: 5 of 11 periods available· newest 2009-12-31
Operating cash flow: 5 of 11 periods available· newest 2009-12-31
Capital expenditure: 5 of 11 periods available· newest 2009-12-31
Total assets: 2 of 11 periods available· newest 2007-12-31
Total liabilities: 4 of 11 periods available· newest 2009-12-31
Current assets: 4 of 11 periods available· newest 2009-12-31
Current liabilities: 4 of 11 periods available· newest 2009-12-31
Cash and cash equivalents: 5 of 11 periods available· newest 2009-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
USD 0

Prior period

USD 0

2008-01-01 – 2008-12-31
Current period

USD 0

2009-01-01 – 2009-12-31

Exact inputs and evidence

0 − 0 = 0 USD

0 USD · 2008-01-01 – 2008-12-31
Inspect prior input Prior source
0 USD · 2009-01-01 – 2009-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · TETRAGENEX PHARMACEUTICALS, INC. · 2009-12-31 TETRAGENEX PHARMACEUTICALS, INC. (edgar:1362659) Year-over-year change in Revenue: 0 USD Concept: fundies:Revenue Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1362659?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 0 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1362659/0001096906-10-000470.txt#3772 Input fundies:Revenue: 0 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1362659/0001096906-10-000470.txt#3772
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 1.14 million

Prior period

−USD 1.11 million

2008-01-01 – 2008-12-31
Current period

USD 34,285

2009-01-01 – 2009-12-31

Exact inputs and evidence

34285 − -1106807 = 1141092 USD

-1106807 USD · 2008-01-01 – 2008-12-31
Inspect prior input Prior source
34285 USD · 2009-01-01 – 2009-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · TETRAGENEX PHARMACEUTICALS, INC. · 2009-12-31 TETRAGENEX PHARMACEUTICALS, INC. (edgar:1362659) Year-over-year change in Net income: 1141092 USD Concept: fundies:NetIncome Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1362659?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: 34285 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1362659/0001096906-10-000470.txt#4689 Input fundies:NetIncome: -1106807 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1362659/0001096906-10-000470.txt#4689
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 104,348

Prior period

−USD 479,732

2008-01-01 – 2008-12-31
Current period

−USD 375,384

2009-01-01 – 2009-12-31

Exact inputs and evidence

-375384 − -479732 = 104348 USD

-479732 USD · 2008-01-01 – 2008-12-31
Inspect prior input Prior source
-375384 USD · 2009-01-01 – 2009-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · TETRAGENEX PHARMACEUTICALS, INC. · 2009-12-31 TETRAGENEX PHARMACEUTICALS, INC. (edgar:1362659) Year-over-year change in Operating cash flow: 104348 USD Concept: fundies:OperatingCashFlow Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1362659?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -375384 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1362659/0001096906-10-000470.txt#4868 Input fundies:OperatingCashFlow: -479732 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1362659/0001096906-10-000470.txt#4868
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-82.6%

Prior period

USD 4,854

2008-01-01 – 2008-12-31
Current period

USD 844

2009-01-01 – 2009-12-31

Exact inputs and evidence

844 − 4854 = -4010 USD

4854 USD · 2008-01-01 – 2008-12-31
Inspect prior input Prior source
844 USD · 2009-01-01 – 2009-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · TETRAGENEX PHARMACEUTICALS, INC. · 2009-12-31 TETRAGENEX PHARMACEUTICALS, INC. (edgar:1362659) Year-over-year change in Capital expenditure: -4010 USD Concept: fundies:CapitalExpenditure Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1362659?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 844 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1362659/0001096906-10-000470.txt#4905 Input fundies:CapitalExpenditure: 4854 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1362659/0001096906-10-000470.txt#4905
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2009 2009-01-01 – 2009-12-31

Revenue USD 0
Operating costs Derived Unavailable An input is unavailable.
Operating income Unavailable An input is unavailable.
Tax, interest and other Derived Unavailable An input is unavailable.
Net income USD 34,285

Cash

Operating cash flow −USD 375,384
Capital expenditure USD 844
Free cash flow Derived −USD 376,228

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2005 Not shown: operating income or net income is not reported.
2006 Not shown: operating income or net income is not reported.
2007 Not shown: operating income or net income is not reported.
2008 Not shown: operating income or net income is not reported.
2009 Not shown: operating income or net income is not reported.

Values and sources

Revenue breakdown by annual reporting period
Period	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2005 2005-01-01 – 2005-12-31	Unavailable	Unavailable	Unavailable	-11780718	-2349147 Derived	Source 2005-01-01 – 2005-12-31: 0 USD Inspect Revenue Open source 2005-01-01 – 2005-12-31: -11780718 USD Inspect Net Income Open source 2005-01-01 – 2005-12-31: -2344775 USD Inspect Operating Cash Flow Open source 2005-01-01 – 2005-12-31: 4372 USD Inspect Capital Expenditure Open source
2006 2006-01-01 – 2006-12-31	Unavailable	Unavailable	Unavailable	-2964001	-1578576 Derived	Source 2006-01-01 – 2006-12-31: 0 USD Inspect Revenue Open source 2006-01-01 – 2006-12-31: -2964001 USD Inspect Net Income Open source 2006-01-01 – 2006-12-31: -1575091 USD Inspect Operating Cash Flow Open source 2006-01-01 – 2006-12-31: 3485 USD Inspect Capital Expenditure Open source
2007 2007-01-01 – 2007-12-31	Unavailable	Unavailable	Unavailable	-4579958	-1369603 Derived	Source 2007-01-01 – 2007-12-31: 0 USD Inspect Revenue Open source 2007-01-01 – 2007-12-31: -4579958 USD Inspect Net Income Open source 2007-01-01 – 2007-12-31: -1369603 USD Inspect Operating Cash Flow Open source 2007-01-01 – 2007-12-31: 0 USD Inspect Capital Expenditure Open source
2008 2008-01-01 – 2008-12-31	Unavailable	Unavailable	Unavailable	-1106807	-484586 Derived	Source 2008-01-01 – 2008-12-31: 0 USD Inspect Revenue Open source 2008-01-01 – 2008-12-31: -1106807 USD Inspect Net Income Open source 2008-01-01 – 2008-12-31: -479732 USD Inspect Operating Cash Flow Open source 2008-01-01 – 2008-12-31: 4854 USD Inspect Capital Expenditure Open source
2009 2009-01-01 – 2009-12-31	Unavailable	Unavailable	Unavailable	34285	-376228 Derived	Source 2009-01-01 – 2009-12-31: 0 USD Inspect Revenue Open source 2009-01-01 – 2009-12-31: 34285 USD Inspect Net Income Open source 2009-01-01 – 2009-12-31: -375384 USD Inspect Operating Cash Flow Open source 2009-01-01 – 2009-12-31: 844 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 0 2009

Values and sources

Revenue values and source evidence
Period	Series	Source evidence
20052005-12-31	Revenue	Revenue: 0 Open source
20062006-12-31	Revenue	Revenue: 0 Open source
20072007-12-31	Revenue	Revenue: 0 Open source
20082008-12-31	Revenue	Revenue: 0 Open source
20092009-12-31	Revenue	Revenue: 0 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

Not enough comparable data to show this history.

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20052005-12-31	Year over year	No prior comparable period	Revenue: 0 Open source
20062006-12-31	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source
20072007-12-31	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source
20082008-12-31	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source
20092009-12-31	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Not enough comparable data to show this history.

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
2005-12-31	Operating margin	Not reported	Revenue: 0 Open source
2006-12-31	Operating margin	Not reported	Revenue: 0 Open source
2007-12-31	Operating margin	Not reported	Revenue: 0 Open source
2008-12-31	Operating margin	Not reported	Revenue: 0 Open source
2009-12-31	Operating margin	Not reported	Revenue: 0 Open source
20052005-12-31	Net margin	Not reported	Net Income: -11780718 Open source Revenue: 0 Open source
20062006-12-31	Net margin	Not reported	Net Income: -2964001 Open source Revenue: 0 Open source
20072007-12-31	Net margin	Not reported	Net Income: -4579958 Open source Revenue: 0 Open source
20082008-12-31	Net margin	Not reported	Net Income: -1106807 Open source Revenue: 0 Open source
20092009-12-31	Net margin	Not reported	Net Income: 34285 Open source Revenue: 0 Open source
20052005-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -2344775 Open source Capital Expenditure: 4372 Open source
20062006-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -1575091 Open source Capital Expenditure: 3485 Open source
20072007-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -1369603 Open source Capital Expenditure: 0 Open source
20082008-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -479732 Open source Capital Expenditure: 4854 Open source
20092009-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -375384 Open source Capital Expenditure: 844 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -375.4K 2009

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20052005-12-31	Operating cash flow	-2344775	Operating Cash Flow: -2344775 Open source
20062006-12-31	Operating cash flow	-1575091	Operating Cash Flow: -1575091 Open source
20072007-12-31	Operating cash flow	-1369603	Operating Cash Flow: -1369603 Open source
20082008-12-31	Operating cash flow	-479732	Operating Cash Flow: -479732 Open source
20092009-12-31	Operating cash flow	-375384	Operating Cash Flow: -375384 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -376.2K 2009

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20052005-12-31	Free cash flow	-2349147	Operating Cash Flow: -2344775 Open source Capital Expenditure: 4372 Open source
20062006-12-31	Free cash flow	-1578576	Operating Cash Flow: -1575091 Open source Capital Expenditure: 3485 Open source
20072007-12-31	Free cash flow	-1369603	Operating Cash Flow: -1369603 Open source Capital Expenditure: 0 Open source
20082008-12-31	Free cash flow	-484586	Operating Cash Flow: -479732 Open source Capital Expenditure: 4854 Open source
20092009-12-31	Free cash flow	-376228	Operating Cash Flow: -375384 Open source Capital Expenditure: 844 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

317.1% 2007

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2005-12-31	Liabilities / assets	Not reported	No source recorded
20062006-12-31	Liabilities / assets	119.2%	Total Liabilities: 2876523 Open source Total Assets: 2412329 Open source
20072007-12-31	Liabilities / assets	317.1%	Total Liabilities: 3214829 Open source Total Assets: 1013928 Open source
20082008-12-31	Liabilities / assets	Not reported	Total Liabilities: 4056268 Open source
20092009-12-31	Liabilities / assets	Not reported	Total Liabilities: 3386066 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

0.05× 2009

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
2005-12-31	Current assets / current liabilities	Not reported	No source recorded
20062006-12-31	Current assets / current liabilities	2.43×	Current Assets: 2412329 Open source Current Liabilities: 994161 Open source
20072007-12-31	Current assets / current liabilities	0.42×	Current Assets: 561514 Open source Current Liabilities: 1332467 Open source
20082008-12-31	Current assets / current liabilities	0.22×	Current Assets: 808757 Open source Current Liabilities: 3747445 Open source
20092009-12-31	Current assets / current liabilities	0.05×	Current Assets: 177654 Open source Current Liabilities: 3336066 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2005 2005-01-01 – 2005-12-31	−USD 11.78 million Exact value Exact value: -11780718 USD 2005-01-01 – 2005-12-31: -11780718 USD Inspect Net Income Open source Share or cite Citation for Net Income · TETRAGENEX PHARMACEUTICALS, INC. · 2005-12-31 TETRAGENEX PHARMACEUTICALS, INC. (edgar:1362659) Net Income: -11780718 USD Concept: fundies:NetIncome Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1362659/explain?concept=fundies%3ANetIncome&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:NetIncome: -11780718 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1362659/0000930413-07-003143.txt#3054 The citation records this snapshot. The page link may show a newer release later.	−USD 2.34 million Exact value Exact value: -2344775 USD 2005-01-01 – 2005-12-31: -2344775 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · TETRAGENEX PHARMACEUTICALS, INC. · 2005-12-31 TETRAGENEX PHARMACEUTICALS, INC. (edgar:1362659) Operating Cash Flow: -2344775 USD Concept: fundies:OperatingCashFlow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1362659/explain?concept=fundies%3AOperatingCashFlow&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -2344775 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1362659/0000930413-07-003143.txt#3066 The citation records this snapshot. The page link may show a newer release later.	USD 4,372 Exact value Exact value: 4372 USD 2005-01-01 – 2005-12-31: 4372 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · TETRAGENEX PHARMACEUTICALS, INC. · 2005-12-31 TETRAGENEX PHARMACEUTICALS, INC. (edgar:1362659) Capital Expenditure: 4372 USD Concept: fundies:CapitalExpenditure Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1362659/explain?concept=fundies%3ACapitalExpenditure&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 4372 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1362659/0000930413-07-003143.txt#3070 The citation records this snapshot. The page link may show a newer release later.	−USD 2.35 million Calculation and evidence -2344775 − 4372 USD Exact free cash flow: -2349147 USD 2005-01-01 – 2005-12-31: -2344775 USD · Inspect Operating Cash Flow · Source 2005-01-01 – 2005-12-31: 4372 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · TETRAGENEX PHARMACEUTICALS, INC. · 2005-12-31 TETRAGENEX PHARMACEUTICALS, INC. (edgar:1362659) Free cash flow: -2349147 USD Concept: free-cash-flow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1362659?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -2344775 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1362659/0000930413-07-003143.txt#3066 Input fundies:CapitalExpenditure: 4372 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1362659/0000930413-07-003143.txt#3070 The citation records this snapshot. The page link may show a newer release later.
2006 2006-01-01 – 2006-12-31	−USD 2.96 million Exact value Exact value: -2964001 USD 2006-01-01 – 2006-12-31: -2964001 USD Inspect Net Income Open source Share or cite Citation for Net Income · TETRAGENEX PHARMACEUTICALS, INC. · 2006-12-31 TETRAGENEX PHARMACEUTICALS, INC. (edgar:1362659) Net Income: -2964001 USD Concept: fundies:NetIncome Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1362659/explain?concept=fundies%3ANetIncome&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:NetIncome: -2964001 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1362659/0000930413-08-005365.txt#4939 The citation records this snapshot. The page link may show a newer release later.	−USD 1.58 million Exact value Exact value: -1575091 USD 2006-01-01 – 2006-12-31: -1575091 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · TETRAGENEX PHARMACEUTICALS, INC. · 2006-12-31 TETRAGENEX PHARMACEUTICALS, INC. (edgar:1362659) Operating Cash Flow: -1575091 USD Concept: fundies:OperatingCashFlow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1362659/explain?concept=fundies%3AOperatingCashFlow&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1575091 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1362659/0000930413-08-005365.txt#5052 The citation records this snapshot. The page link may show a newer release later.	USD 3,485 Exact value Exact value: 3485 USD 2006-01-01 – 2006-12-31: 3485 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · TETRAGENEX PHARMACEUTICALS, INC. · 2006-12-31 TETRAGENEX PHARMACEUTICALS, INC. (edgar:1362659) Capital Expenditure: 3485 USD Concept: fundies:CapitalExpenditure Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1362659/explain?concept=fundies%3ACapitalExpenditure&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 3485 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1362659/0000930413-08-005365.txt#5083 The citation records this snapshot. The page link may show a newer release later.	−USD 1.58 million Calculation and evidence -1575091 − 3485 USD Exact free cash flow: -1578576 USD 2006-01-01 – 2006-12-31: -1575091 USD · Inspect Operating Cash Flow · Source 2006-01-01 – 2006-12-31: 3485 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · TETRAGENEX PHARMACEUTICALS, INC. · 2006-12-31 TETRAGENEX PHARMACEUTICALS, INC. (edgar:1362659) Free cash flow: -1578576 USD Concept: free-cash-flow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1362659?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -1575091 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1362659/0000930413-08-005365.txt#5052 Input fundies:CapitalExpenditure: 3485 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1362659/0000930413-08-005365.txt#5083 The citation records this snapshot. The page link may show a newer release later.
2007 2007-01-01 – 2007-12-31	−USD 4.58 million Exact value Exact value: -4579958 USD 2007-01-01 – 2007-12-31: -4579958 USD Inspect Net Income Open source Share or cite Citation for Net Income · TETRAGENEX PHARMACEUTICALS, INC. · 2007-12-31 TETRAGENEX PHARMACEUTICALS, INC. (edgar:1362659) Net Income: -4579958 USD Concept: fundies:NetIncome Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1362659/explain?concept=fundies%3ANetIncome&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:NetIncome: -4579958 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1362659/0001096906-09-000282.txt#5799 The citation records this snapshot. The page link may show a newer release later.	−USD 1.37 million Exact value Exact value: -1369603 USD 2007-01-01 – 2007-12-31: -1369603 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · TETRAGENEX PHARMACEUTICALS, INC. · 2007-12-31 TETRAGENEX PHARMACEUTICALS, INC. (edgar:1362659) Operating Cash Flow: -1369603 USD Concept: fundies:OperatingCashFlow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1362659/explain?concept=fundies%3AOperatingCashFlow&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1369603 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1362659/0001096906-09-000282.txt#5943 The citation records this snapshot. The page link may show a newer release later.	USD 0 Exact value Exact value: 0 USD 2007-01-01 – 2007-12-31: 0 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · TETRAGENEX PHARMACEUTICALS, INC. · 2007-12-31 TETRAGENEX PHARMACEUTICALS, INC. (edgar:1362659) Capital Expenditure: 0 USD Concept: fundies:CapitalExpenditure Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1362659/explain?concept=fundies%3ACapitalExpenditure&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 0 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1362659/0000930413-08-005365.txt#5083 The citation records this snapshot. The page link may show a newer release later.	−USD 1.37 million Calculation and evidence -1369603 − 0 USD Exact free cash flow: -1369603 USD 2007-01-01 – 2007-12-31: -1369603 USD · Inspect Operating Cash Flow · Source 2007-01-01 – 2007-12-31: 0 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · TETRAGENEX PHARMACEUTICALS, INC. · 2007-12-31 TETRAGENEX PHARMACEUTICALS, INC. (edgar:1362659) Free cash flow: -1369603 USD Concept: free-cash-flow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1362659?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -1369603 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1362659/0001096906-09-000282.txt#5943 Input fundies:CapitalExpenditure: 0 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1362659/0000930413-08-005365.txt#5083 The citation records this snapshot. The page link may show a newer release later.
2008 2008-01-01 – 2008-12-31	−USD 1.11 million Exact value Exact value: -1106807 USD 2008-01-01 – 2008-12-31: -1106807 USD Inspect Net Income Open source Share or cite Citation for Net Income · TETRAGENEX PHARMACEUTICALS, INC. · 2008-12-31 TETRAGENEX PHARMACEUTICALS, INC. (edgar:1362659) Net Income: -1106807 USD Concept: fundies:NetIncome Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1362659/explain?concept=fundies%3ANetIncome&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:NetIncome: -1106807 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1362659/0001096906-10-000470.txt#4689 The citation records this snapshot. The page link may show a newer release later.	−USD 479,732 Exact value Exact value: -479732 USD 2008-01-01 – 2008-12-31: -479732 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · TETRAGENEX PHARMACEUTICALS, INC. · 2008-12-31 TETRAGENEX PHARMACEUTICALS, INC. (edgar:1362659) Operating Cash Flow: -479732 USD Concept: fundies:OperatingCashFlow Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1362659/explain?concept=fundies%3AOperatingCashFlow&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -479732 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1362659/0001096906-10-000470.txt#4868 The citation records this snapshot. The page link may show a newer release later.	USD 4,854 Exact value Exact value: 4854 USD 2008-01-01 – 2008-12-31: 4854 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · TETRAGENEX PHARMACEUTICALS, INC. · 2008-12-31 TETRAGENEX PHARMACEUTICALS, INC. (edgar:1362659) Capital Expenditure: 4854 USD Concept: fundies:CapitalExpenditure Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1362659/explain?concept=fundies%3ACapitalExpenditure&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 4854 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1362659/0001096906-10-000470.txt#4905 The citation records this snapshot. The page link may show a newer release later.	−USD 484,586 Calculation and evidence -479732 − 4854 USD Exact free cash flow: -484586 USD 2008-01-01 – 2008-12-31: -479732 USD · Inspect Operating Cash Flow · Source 2008-01-01 – 2008-12-31: 4854 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · TETRAGENEX PHARMACEUTICALS, INC. · 2008-12-31 TETRAGENEX PHARMACEUTICALS, INC. (edgar:1362659) Free cash flow: -484586 USD Concept: free-cash-flow Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1362659?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -479732 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1362659/0001096906-10-000470.txt#4868 Input fundies:CapitalExpenditure: 4854 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1362659/0001096906-10-000470.txt#4905 The citation records this snapshot. The page link may show a newer release later.
2009 2009-01-01 – 2009-12-31	USD 34,285 Exact value Exact value: 34285 USD 2009-01-01 – 2009-12-31: 34285 USD Inspect Net Income Open source Share or cite Citation for Net Income · TETRAGENEX PHARMACEUTICALS, INC. · 2009-12-31 TETRAGENEX PHARMACEUTICALS, INC. (edgar:1362659) Net Income: 34285 USD Concept: fundies:NetIncome Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1362659/explain?concept=fundies%3ANetIncome&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:NetIncome: 34285 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1362659/0001096906-10-000470.txt#4689 The citation records this snapshot. The page link may show a newer release later.	−USD 375,384 Exact value Exact value: -375384 USD 2009-01-01 – 2009-12-31: -375384 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · TETRAGENEX PHARMACEUTICALS, INC. · 2009-12-31 TETRAGENEX PHARMACEUTICALS, INC. (edgar:1362659) Operating Cash Flow: -375384 USD Concept: fundies:OperatingCashFlow Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1362659/explain?concept=fundies%3AOperatingCashFlow&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -375384 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1362659/0001096906-10-000470.txt#4868 The citation records this snapshot. The page link may show a newer release later.	USD 844 Exact value Exact value: 844 USD 2009-01-01 – 2009-12-31: 844 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · TETRAGENEX PHARMACEUTICALS, INC. · 2009-12-31 TETRAGENEX PHARMACEUTICALS, INC. (edgar:1362659) Capital Expenditure: 844 USD Concept: fundies:CapitalExpenditure Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1362659/explain?concept=fundies%3ACapitalExpenditure&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 844 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1362659/0001096906-10-000470.txt#4905 The citation records this snapshot. The page link may show a newer release later.	−USD 376,228 Calculation and evidence -375384 − 844 USD Exact free cash flow: -376228 USD 2009-01-01 – 2009-12-31: -375384 USD · Inspect Operating Cash Flow · Source 2009-01-01 – 2009-12-31: 844 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · TETRAGENEX PHARMACEUTICALS, INC. · 2009-12-31 TETRAGENEX PHARMACEUTICALS, INC. (edgar:1362659) Free cash flow: -376228 USD Concept: free-cash-flow Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1362659?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -375384 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1362659/0001096906-10-000470.txt#4868 Input fundies:CapitalExpenditure: 844 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1362659/0001096906-10-000470.txt#4905 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

19 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001362659, 1362659, edgar:1362659

TETRAGENEX PHARMACEUTICALS, INC.

Latest quarter

Revenue

Operating cash flow

Free cash flow

Trailing twelve months

Net income

Operating cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2009 2009-01-01 – 2009-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation